Drug Trial Radar · NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Mar 14, 2024
Primary completion
Oct 5, 2028
Study completion Jan 9, 2030
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus (SLE)
Conditions
- Systemic Lupus Erythematosus
Interventions
AnifrolumabBiological
Participants will receive anifrolumab via IV infusion.
PlaceboDrug
Participants will receive matching placebo via IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A- Anifrolumab serum concentrationTime frame: Pre-dose Day 29
- Part A - Maximum observed serum (peak) drug concentration (Cmax)Time frame: Up to Day 29
- Part A - Area under the serum concentration curve (AUC)Time frame: Up to Day 29
- Part A - Minimum observed serum concentration (Cmin)Time frame: Up to Day 29
- Part B - Number of participants who are British Isles Lupus Assessment Group-based Composite Lupus Assessment (BICLA) responders (yes/no)Time frame: At Week 52
Locations
111 sites in 18 countries. Site status is shown where the registry gives one.
Research Site
Phoenix, Arizona · Recruiting
Research Site
Los Angeles, California · Recruiting
Research Site
Washington D.C., District of Columbia · Recruiting
Research Site
St. Petersburg, Florida · Not yet recruiting
Research Site
Chicago, Illinois · Recruiting
Research Site
Chicago, Illinois · Recruiting
Research Site
New Orleans, Louisiana · Recruiting
Research Site
Bethesda, Maryland · Withdrawn
Research Site
Saint Paul, Minnesota · Recruiting
Research Site
New Hyde Park, New York · Recruiting
Research Site
New York, New York · Recruiting
Research Site
The Bronx, New York · Recruiting
Research Site
Valhalla, New York · Recruiting
Research Site
Durham, North Carolina · Recruiting
Research Site
Cincinnati, Ohio · Recruiting
Research Site
Cleveland, Ohio · Recruiting
Research Site
Columbus, Ohio · Recruiting
Research Site
Portland, Oregon · Recruiting
Research Site
Philadelphia, Pennsylvania · Recruiting
Research Site
Greenville, South Carolina · Withdrawn
Research Site
El Paso, Texas · Recruiting
Research Site
Houston, Texas · Recruiting
Research Site
Salt Lake City, Utah · Recruiting
Research Site
Buenos Aires, Argentina · Withdrawn
Research Site
Córdoba, Argentina · Recruiting
Research Site
Rosario, Argentina · Recruiting
Research Site
San Miguel de Tucumán, Argentina · Recruiting
Research Site
Belo Horizonte, Brazil · Not yet recruiting
Research Site
Belo Horizonte, Brazil · Not yet recruiting
Research Site
Belo Horizonte, Brazil · Not yet recruiting
Research Site
Porto Alegre, Brazil · Recruiting
Research Site
Ribeirão Preto, Brazil · Recruiting
Research Site
São Paulo, Brazil · Recruiting
Research Site
São Paulo, Brazil · Recruiting
Research Site
Calgary, Alberta, Canada · Not yet recruiting
Research Site
Vancouver, British Columbia, Canada · Recruiting
Research Site
Toronto, Ontario, Canada · Recruiting
Research Site
Beijing, China · Withdrawn
Research Site
Beijing, China · Not yet recruiting
Research Site
Beijing, China · Recruiting
Showing 40 of 111 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.